VCFrance

The most common chronic disease in children, moderate to severe asthma remains imperfectly treated by current inhalation devices, leading to a high impact on school absenteeism and the quality of life of young patients. A population that has become a

VCFrance

The healthcare venture firm closes its fourth biotech fund, up 35%, and confirms a still-minority strategy in Europe: combining company creation and early-stage investments.Kurma Partners announces the final closing of Biofund IV at €215M, versus €16

VCFrance

Fueled by the rise of AI, BrainTech is asserting itself as one of the most promising segments of digital health. With a €60 million fund, Newfund intends to structure a market still largely dominated by the United States.USD 4.2 billion raised global

VCFrance

By closing its second fund, Jeito II, at more than one billion euros, Jeito Capital posts a record raise and brings its assets under management to €1.6 billion in five years.After a first vehicle raised at €534 million in 2021, Jeito Capital closes i

VCFrance

With a $320M fund launched in 2022, Pictet Alternative Advisors is deploying a private equity strategy entirely dedicated to health, from upstream innovation to care services, investing in the United States, Europe and Asia. The vehicle targets aroun

VCFrance

Innovation in health is no longer merely a scientific or economic issue: it has become a field of strategic confrontation. The United States, whichremain the leading financial and biotechnological power, are experiencing structural weakening, caught